Anticoagulation in Atrial Fibrillation and Chronic Kidney Disease: A Critical Review and Future Perspectives in Peritoneal Dialysis
Year: 2026
Type: article
Abstract: Atrial fibrillation (AF) and chronic kidney disease (CKD) are two closely related pathophysiologically interconnected conditions, sharing common risk factors and resulting in poor clinical outcomes when coexisting. In patients with end-stage renal disease (ESRD) on renal replacement therapy, AF significantly complicates clinical management, as these patients have a doubled risk of death, stroke, and bleeding. Choosing the optimal anticoagulant strategy remains a major challenge, with direct oral anticoagulants (DOACs) emerging as a potentially superior alternative to vitamin K antagonists (VKAs), especially due to their renoprotective profile. However, data in patients on peritoneal dialysis (PD) remain sparse, constituting a significant gap in the scientific literature. This review examines the current state of evidence on anticoagulation in patients with AF and advanced CKD, with a particular focus on new therapeutic perspectives in the PD population.
DOI: 10.14740/wjnu1037
Institution: Ospedale regionale di Lugano
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W7140129784
FWCI:
Cites:
Cited by:
Related to:
